Cyberonics, Inc. (NASDAQ:CYBX)

CAPS Rating: 4 out of 5

A neuromodulation company founded to design, develop and bring to market medical devices that provide a unique therapy, VNS Therapy, for the treatment of epilepsy, TRD and other debilitating neurological or psychiatric diseases and other disorders.

Recs

0
Player Avatar mjan706 (60.17) Submitted: 9/22/2008 1:44:10 AM : Outperform Start Price: $17.97 CYBX Score: +107.41

An Icahn portfolio stock.

Featured Broker Partners


Advertisement